Skip to content

Insider · CIK 0001517740

Kirk P McDonald

director

Files at ZD (ZIFF DAVIS, INC.), ELAN (Elanco Animal Health Inc). First filing Jun 8, 2026, latest Jun 8, 2026.

Kirk P McDonald files SEC Form 4 as director at ZD (ZIFF DAVIS, INC.), and also at ELAN (Elanco Animal Health Inc). Since Jun 8, 2026, Kirk P McDonald has reported 0 open-market buys worth $0 and 1 open-market sell worth $50k, the latest filed on Jun 8, 2026.

A track record needs three past buys with six months of prices behind them; Kirk P McDonald has 0, so none is measured yet.

The newest scored trade: sold $50k of ZD on Jun 8, 2026, filed Jun 8, 2026, scored 37 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $50k.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $50k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ZD: ZIFF DAVIS, INC.

ZDOct 9, 2026 · close 56.52

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
37Weak
ZDsell 5
ZIFF DAVIS, INC.
$50k
1,075 shares
-7%+76% from low-3% from high

Transactions

Every row this insider has filed, 14 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 8, 2026ZD
ZIFF DAVIS, INC.
SOpen-market sale
Common Stock, $0.01 par value
-975$46.65$45k13,568Jun 8, 2026
Jun 8, 2026ZD
ZIFF DAVIS, INC.
SOpen-market sale
Common Stock, $0.01 par value
-100$46.66$4,66613,468Jun 8, 2026
May 21, 2026ELAN
Elanco Animal Health Inc
AGrant or award
Common Stock
+4,678$0.00$093,392May 26, 2026
May 21, 2026ELAN
Elanco Animal Health Inc
AGrant or award
Common Stock
+12,196$0.00$0105,588May 26, 2026
May 7, 2026ZD
ZIFF DAVIS, INC.
MOption exercise
Common Stock $0.01 Par Value
+7,903$43.31$342k14,543May 8, 2026
May 7, 2025ZD
ZIFF DAVIS, INC.
MOption exercise
Restricted Stock Unitsderivative
-7,903$0.00$00May 8, 2026
May 6, 2026ZD
ZIFF DAVIS, INC.
AGrant or award
Restricted Stock Unitsderivative
+5,723$0.00$05,723May 8, 2026
Nov 28, 2025ELAN
Elanco Animal Health Inc
AGrant or award
Common Stock
+10,314$0.00$088,714Dec 2, 2025
May 7, 2025ZD
ZIFF DAVIS, INC.
MOption exercise
Common Stock $0.01 Par Value
+3,610$31.63$114k6,640May 9, 2025
May 7, 2024ZD
ZIFF DAVIS, INC.
MOption exercise
Restricted Stock Unitsderivative
-3,610$0.00$00May 9, 2025
May 7, 2025ZD
ZIFF DAVIS, INC.
AGrant or award
Restricted Stock Unitsderivative
+7,903$0.00$07,903May 9, 2025
Nov 29, 2024ELAN
Elanco Animal Health Inc
AGrant or award
Common Stock
+18,169$0.00$078,400Dec 3, 2024
Nov 15, 2024ZD
ZIFF DAVIS, INC.
MOption exercise
Common Stock $0.01 Par Value
+3,030--3,030Nov 18, 2024
Nov 15, 2024ZD
ZIFF DAVIS, INC.
MOption exercise
Restricted Stock Unitsderivative
-3,030$0.00$03,611Nov 18, 2024

Questions about Kirk P McDonald

Answered from the filings on this page, as of the latest one.

Is Kirk P McDonald buying or selling?

In the last 12 months Kirk P McDonald reported 0 open-market buys worth $0 and 1 open-market sell worth $50k on SEC Form 4; the latest was sold $50k of ZD on Jun 8, 2026. Grants, option exercises and tax withholding are not counted.

How did Kirk P McDonald's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kirk P McDonald has 0.

Where does Kirk P McDonald file Form 4?

Kirk P McDonald has filed Form 4 at ZD (ZIFF DAVIS, INC.); ELAN (Elanco Animal Health Inc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.